Endo Health Solutions, Inc. (ENDP)
Q2 2012 Earnings Conference Call
August 07, 2012, 08:30 a.m. ET
Blaine Davis - SVP, Corporate Affairs
Dave Holveck - President and CEO
Julie McHugh - COO
Ivan Gergel - EVP, Research & Development and Chief Scientific Officer
Alan Levin - EVP and CFO
Marc Goodman - UBS
Ken Cacciatore - Cowen and Company
Shibani Malhotra - RBC Capital Markets
Gregg Gilbert - Bank of America/Merrill Lynch
Corey Davis - Jefferies and Company
Annabel Samimy - Stifel Nicolaus
Trevor Davis - Piper Jaffray
Mike Faerm - Credit Suisse
Chris Schott - JP Morgan
Gary Nachman - Susquehanna Financial Group
Greg Waterman - Goldman Sachs
Good day ladies and gentlemen, and welcome to Q2 2012 Endo Health Solutions Inc. Earnings Conference Call. My name is Sonia and I will be your operator for today. At this point, all participants are in listen-only mode. We will conduct the Q&A session towards the end of this conference call. (Operator Instructions) As a reminder this call is being recorded for replay purposes.
I’d like to turn the call over to Blaine Davis, Senior Vice President of Corporate Affairs. Please proceed.
Good morning. Thank you for joining us today. With me on this morning’s call are Dave Holveck, President and CEO of Endo; Julie McHugh, Chief Operating Officer; Dr. Ivan Gergel, Chief Scientific Officer; and Alan Levin, Chief Financial Officer.